Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine on Microcirculation in Septic Shock
NCT02612181Phase 4Unknown
- Sponsor
- Southeast University
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in septic shock, sponsored by Southeast University. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02612181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02612181.